EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy

Jorge Fonseca, Maria Francisca Moraes-Fontes, Inês Sousa, Francisco Oliveira, Gonçalo Froes, Ana Gaivão, Artur Palmas, Jorge Rebola, Ciprian Muresan, Tiago Santos, Daniela Dias, Mário Varandas und 3 weitere

Journal of Robotic Surgery · 29.05.2024 · 18 (1)

DOI: 10.1007/s11701-024-01986-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Robotic Surgery, online erschienen am 29.05.2024. Verfasst von Jorge Fonseca und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Av. Brasília, 1400-038, Lisboa, Portugal. jorge.fonseca@fundacaochampalima…. Hauptthemen laut MEDLINE: Prostatectomy, Robotic Surgical Procedures, Urinary Incontinence, Urethra. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The influence of anatomical parameters on urinary continence (UC) after Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) remains uncharted. Our objective was to evaluate their association with UC at 3, 6 and 12 months post-operatively. Data from patients who underwent RS-RARP were prospectively collected. Continence was defined as no pad use. Anatomic variables were measured on preoperative magnetic resonance imaging (MRI). Regression analyses were performed to identify predictors of UC at each time point. We included 158 patients with a median age of 60 years, most of whom had a localized tumor (≤ cT2). On multivariate analyses, at 3 months post-surgery, urinary incontinence (UI) rises with age, odds ratio (OR) 1.07 [95% confidence interval (CI) 1.004−1.142] and with prostate volume (PV), OR 1.029 (95% CI 1.006−1.052); it reduces with longer membranous urethral length (MUL), OR 0.875 (95% CI 0.780−0.983) and with higher membranous urethral volume (MUV), OR 0.299 (95% CI 0.121−0.737). At 6 months, UI rises with PV, OR 1.033 (95% CI 1.011−1.056) and decreases with MUV, OR 0.1504 (95% CI 0.050−0.444). Significantly, at 12 months post-surgery, the only predictor of UI is MUL, OR 0.830 (95% CI 0.706−0.975), establishing a threshold associated with a risk of UI of 5% (MUL > 15 mm) in opposition to a risk of 25% (MUL < 10 mm). This single institutional study requires external validation. To our knowledge, this is the first prospective cohort study supporting MUL as the single independent predictor of UC at 12 months post-surgery. By establishing MUL thresholds, we enable precise patient counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyRobotic Surgical ProceduresUrinary IncontinenceUrethraProstatic NeoplasmsHumansMaleMiddle AgedAgedOrgan Sparing TreatmentsMagnetic Resonance ImagingProspective StudiesPostoperative ComplicationsRecovery of FunctionProstateTime Factors

Stichwörter der Autor:innen

Magnetic resonance imagingPrognostic toolProstate cancerRetzius-sparing robot-assisted radical prostatectomyUrinary incontinence

Autor:innen und Institutionen

  • Unidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Av. Brasília, 1400-038, Lisboa, Portugal. jorge.fonseca@fundacaochampalimaud.pt.
  • Instituto de Ciências Biomédicas Abel Salazar, Universidade Do Porto, Porto, Portugal. jorge.fonseca@fundacaochampalimaud.pt.
  • Unidade de Imuno-Oncologia, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
  • Unidade de Investigação Clínica, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
  • Serviço de Medicina Nuclear, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
  • Faculté de Médecine Et Médecine Dentaire, Université Catholique de Louvain, Brussels, Belgium.

Förderung

  • Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud

Zitieren

APA

Fonseca, J., Moraes-Fontes, M. F., Sousa, I., Oliveira, F., Froes, G., Gaivão, A., Palmas, A., Rebola, J., Muresan, C., Santos, T., Dias, D., Varandas, M., Lopez-Beltran, A., Ribeiro, R., & Fraga, A. (2024). Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy. Journal of Robotic Surgery, 18(1). https://doi.org/10.1007/s11701-024-01986-8

Vancouver

Fonseca J, Moraes-Fontes MF, Sousa I, Oliveira F, Froes G, Gaivão A, et al. Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy. Journal of Robotic Surgery. 2024;18(1). doi:10.1007/s11701-024-01986-8

BibTeX
@article{Fonseca2024,
  author = {Fonseca, Jorge and Moraes-Fontes, Maria Francisca and Sousa, Inês and Oliveira, Francisco and Froes, Gonçalo and Gaivão, Ana and Palmas, Artur and Rebola, Jorge and Muresan, Ciprian and Santos, Tiago and Dias, Daniela and Varandas, Mário and Lopez-Beltran, Antonio and Ribeiro, Ricardo and Fraga, Avelino},
  title = {Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy},
  journal = {Journal of Robotic Surgery},
  year = {2024},
  volume = {18},
  number = {1},
  doi = {10.1007/s11701-024-01986-8}
}
Kostenlos starten →